{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:13:51Z","timestamp":1787030031074,"version":"build-2736575974"},"reference-count":113,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI129540"],"award-info":[{"award-number":["AI129540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI148304"],"award-info":[{"award-number":["AI148304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI179734"],"award-info":[{"award-number":["AI179734"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI189583"],"award-info":[{"award-number":["AI189583"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Chronic hepatitis B virus (HBV) infection is a major health problem that leads to approximately one million deaths every year worldwide. Mother-to-child transmission (MTCT) is the major cause of chronic HBV infection. HBV e antigen (HBeAg) is a secretory viral protein and modulates the immunological landscape of the newborn to promote HBV persistence. HBeAg actively reprograms innate and adaptive immunity. Mechanistically, HBeAg regulates macrophage polarization, suppresses dendritic cell and natural killer (NK) cell activities, impairs T cell and B cell functions, and promotes the expansion of myeloid-derived suppressor cells (MDSCs). These multifaceted effects contribute to immune tolerance and persistent HBV infection in the offspring of carrier mothers. Clinically, HBeAg status is a critical determinant for MTCT risk stratification and intervention, particularly in resource-limited settings. Despite advances in neonatal immunoprophylaxis and maternal antiviral therapy, residual transmission of HBV persists. Emerging approaches targeting HBeAg directly or restoring antiviral immunity offer promising avenues for breaking immune tolerance and achieving HBV elimination. This review summarizes current understanding of HBeAg-mediated immune modulation and highlights strategies that are being used to disrupt MTCT and treat HBV patients.<\/jats:p>","DOI":"10.3390\/v17111484","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:57:55Z","timestamp":1762765075000},"page":"1484","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatitis B Virus e Antigen in Mother-to-Child Transmission and Clinical Management of Hepatitis B"],"prefix":"10.3390","volume":"17","author":[{"given":"Qiqi","family":"Ning","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8274-5705","authenticated-orcid":false,"given":"Jing-hsiung James","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"ref_1","unstructured":"The Polaris Observatory Collaborators (2023). Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: A modelling study. Lancet Gastroenterol. Hepatol., 8, 879\u2013907."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.coviro.2021.10.003","article-title":"Hepatitis B virus e antigen and viral persistence","volume":"51","author":"Tsai","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","article-title":"The e antigen and vertical transmission of hepatitis B surface antigen","volume":"105","author":"Beasley","year":"1977","journal-title":"Am. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM197604012941402","article-title":"e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants","volume":"294","author":"Okada","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/infdis\/jiy706","article-title":"The Impact of Universal Infant Hepatitis B Immunization on Reducing the Hepatitis B Carrier Rate in Pregnant Women","volume":"220","author":"Su","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.83.6.1578","article-title":"Hepatitis B virus gene function: The precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen","volume":"83","author":"Ou","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.02348-08","article-title":"Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme","volume":"83","author":"Ito","year":"2009","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.str.2012.10.017","article-title":"Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein","volume":"21","author":"DiMattia","year":"2013","journal-title":"Structure"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1128\/jvi.67.7.3756-3762.1993","article-title":"Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis","volume":"67","author":"Lamberts","year":"1993","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1128\/jvi.70.10.7056-7061.1996","article-title":"The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice","volume":"70","author":"Guidotti","year":"1996","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chuang, Y.C., and Ou, J.H. (2025). Effects of cellular membranes and the precore protein on hepatitis B virus core particle assembly and DNA replication. mBio, 16.","DOI":"10.1128\/mbio.03972-24"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.str.2018.06.012","article-title":"Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition","volume":"26","author":"Eren","year":"2018","journal-title":"Structure"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.4049\/jimmunol.130.6.2903","article-title":"Immunochemical structure of hepatitis B e antigen in the serum","volume":"130","author":"Takahashi","year":"1983","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11262-020-01733-9","article-title":"Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: A potential source of misunderstandings","volume":"56","author":"Gerlich","year":"2020","journal-title":"Virus Genes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/jvi.61.10.3322-3325.1987","article-title":"Expression of the precore region of an avian hepatitis B virus is not required for viral replication","volume":"61","author":"Chang","year":"1987","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0016-5085(80)90130-4","article-title":"Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection","volume":"79","author":"Realdi","year":"1980","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3748\/wjg.v11.i19.2869","article-title":"Presence and integration of HBV DNA in mouse oocytes","volume":"11","author":"Huang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/humrep\/der103","article-title":"The presence and expression of the hepatitis B virus in human oocytes and embryos","volume":"26","author":"Hu","year":"2011","journal-title":"Hum. Reprod."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/aja.aja_46_17","article-title":"Transcription and regulation of hepatitis B virus genes in host sperm cells","volume":"20","author":"Zhong","year":"2018","journal-title":"Asian J. Androl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7262.2006.00141.x","article-title":"Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome","volume":"8","author":"Ali","year":"2006","journal-title":"Asian J. Androl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.fertnstert.2010.12.043","article-title":"Presence of hepatitis B virus in oocytes and embryos: A risk of hepatitis B virus transmission during in vitro fertilization","volume":"95","author":"Nie","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jmv.10493","article-title":"Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies","volume":"71","author":"Wang","year":"2003","journal-title":"J. Med. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(00)90021-7","article-title":"Infection of the fetus with hepatitis B e antigen via the placenta","volume":"355","author":"Wang","year":"2000","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e12914","DOI":"10.1111\/sji.12914","article-title":"Effects of intrauterine exposure to maternal-derived HBeAg on T cell immunity in cord blood","volume":"92","author":"Huang","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0002-9378(84)90045-0","article-title":"Placental transmission of hepatitis B e antigen and clinical significance of hepatitis B e antigen titers in children born to hepatitis B e antigen-positive carrier women","volume":"149","author":"Inaba","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1203\/00006450-198203000-00017","article-title":"Maternofetal transmission of IgG-bound hepatitis B e antigen","volume":"16","author":"Arakawa","year":"1982","journal-title":"Pediatr. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3476(87)80210-X","article-title":"Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus","volume":"111","author":"Lin","year":"1987","journal-title":"J. Pediatr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"249.e1","DOI":"10.1016\/j.ajog.2023.07.032","article-title":"Risk of mother-to-child transmission after amniocentesis in pregnant women with hepatitis B virus: A retrospective cohort study","volume":"230","author":"Du","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2011.10.041","article-title":"An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus","volume":"10","author":"Pan","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jvh.13314","article-title":"The role of caesarean section and nonbreastfeeding in preventing mother-to-child transmission of hepatitis B virus in HBsAg-and HBeAg-positive mothers: Results from a prospective cohort study and a meta-analysis","volume":"27","author":"Pan","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_32","first-page":"207","article-title":"Hepatitis B virus in the colostra of HBeAg-positive carrier mothers","volume":"17","author":"Lin","year":"1993","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1038\/ncomms7588","article-title":"Trained immunity in newborn infants of HBV-infected mothers","volume":"6","author":"Hong","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.4049\/jimmunol.0803683","article-title":"Interaction of the hepatitis B core antigen and the innate immune system","volume":"182","author":"Lee","year":"2009","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: Time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Li, Y., Wu, C., Lee, J., Ning, Q., Lim, J., Eoh, H., Wang, S., Hurrell, B.P., Akbari, O., and Ou, J.J. (2024). Hepatitis B virus e antigen induces atypical metabolism and differentially regulates programmed cell deaths of macrophages. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012079"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Liu, Y., Xu, R., Gu, H., Zhang, E., Qu, J., Cao, W., Huang, X., Yan, H., He, J., and Cai, Z. (2021). Metabolic reprogramming in macrophage responses. Biomark. Res., 9.","DOI":"10.1186\/s40364-020-00251-y"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"110284","DOI":"10.1016\/j.celrep.2021.110284","article-title":"Macrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1\u03b2 to downregulate PPAR\u03b1 and FOXO3","volume":"38","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"31715","DOI":"10.1074\/jbc.M113.501122","article-title":"Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)","volume":"288","author":"Watashi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00018-018-2753-8","article-title":"HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines","volume":"75","author":"Wang","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00109-023-02405-5","article-title":"Phosphorylation of RGS16 at Tyr168 promote HBeAg-mediated macrophage activation by ERK pathway to accelerate liver injury","volume":"102","author":"Tian","year":"2024","journal-title":"J. Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3892\/mmr.2023.12950","article-title":"M1 macrophages may be effective adjuvants for promoting Th-17 differentiation in HBeAg positive hepatitis patients with ALT \u2264 2ULN","volume":"27","author":"Sun","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"G459","DOI":"10.1152\/ajpgi.00338.2021","article-title":"Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization","volume":"322","author":"Li","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bility, M.T., Cheng, L., Zhang, Z., Luan, Y., Li, F., Chi, L., Zhang, L., Tu, Z., Gao, Y., and Fu, Y. (2014). Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: Induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004032"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","article-title":"HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1\u03b2 production via suppressing the NF-\u03baB pathway and ROS production","volume":"66","author":"Yu","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijid.2016.03.024","article-title":"Impact of HBeAg on the maturation and function of dendritic cells","volume":"46","author":"Lan","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.imbio.2014.07.020","article-title":"Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation","volume":"219","author":"Hatipoglu","year":"2014","journal-title":"Immunobiology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Woltman, A.M., Op den Brouw, M.L., Biesta, P.J., Shi, C.C., and Janssen, H.L. (2011). Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0015324"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Li, W., Jiang, Y., Wang, X., Jin, J., Qi, Y., Chi, X., Zhang, H., Feng, X., and Niu, J. (2015). Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135874"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s12072-024-10689-z","article-title":"HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B","volume":"18","author":"Feng","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1128\/JVI.00111-14","article-title":"Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen","volume":"88","author":"Jegaskanda","year":"2014","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.intimp.2016.06.015","article-title":"Hepatitis B virus antigens impair NK cell function","volume":"38","author":"Yang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ma, Q., Dong, X., Liu, S., Zhong, T., Sun, D., Zong, L., Zhao, C., Lu, Q., Zhang, M., and Gao, Y. (2020). Hepatitis B e Antigen Induces NKG2A(+) Natural Killer Cell Dysfunction via Regulatory T Cell-Derived Interleukin 10 in Chronic Hepatitis B Virus Infection. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00421"},{"key":"ref_60","first-page":"3679","article-title":"Hepatitis B envelope antigen increases Tregs by converting CD4+CD25(-) T cells into CD4(+)CD25(+)Foxp3(+) Tregs","volume":"20","author":"Tang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12072-017-9803-4","article-title":"Functional restoration of CD56(bright) NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B","volume":"11","author":"Chen","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1089\/vim.2023.0018","article-title":"Hepatitis B Virus Envelope Antigen and Hepatitis B Virus Surface Antigen Both Contribute to the Innate Immune Response During Persistent Hepatitis B Virus Infection","volume":"36","author":"Zhang","year":"2023","journal-title":"Viral Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10875-010-9483-5","article-title":"Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients","volume":"31","author":"Peng","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2019.08.024","article-title":"TNF-\u03b1\/IFN-\u03b3 profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection","volume":"72","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1365-2893.2008.00996.x","article-title":"Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B","volume":"15","author":"Vassilopoulos","year":"2008","journal-title":"J. Viral Hepat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-014-0251-9","article-title":"Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients","volume":"12","author":"Wang","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","article-title":"IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection","volume":"189","author":"Das","year":"2012","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2016.03.011","article-title":"Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-\u03b1 therapy","volume":"73","author":"Zhang","year":"2016","journal-title":"Mol. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/21645515.2019.1575712","article-title":"Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: Implication for the role of HBeAg as an immunotolerogen","volume":"15","author":"Huang","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Jiang, H., Chen, C., Yuan, D., Ye, X., Chen, Y., Han, G., Zhou, G., Ju, Y., and Cao, M. (2023). The relationship of maternal hepatitis B e antigen and response to vaccination of infants born to women with chronic infection. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05815-y"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/21645515.2019.1607132","article-title":"Is the function of the HBeAg really unknown?","volume":"15","author":"Milich","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Yang, F., Yu, X., Zhou, C., Mao, R., Zhu, M., Zhu, H., Ma, Z., Mitra, B., Zhao, G., and Huang, Y. (2019). Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007690"},{"key":"ref_75","unstructured":"UNICEF (2023, August 15). Immunization Coverage Estimates Data Visualization. Available online: https:\/\/data.unicef.org\/resources\/immunization-coverage-estimates-data-visualization\/."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Solomon-Rakiep, T., Olivier, J., and Amponsah-Dacosta, E. (2023). Weak Adoption and Performance of Hepatitis B Birth-Dose Vaccination Programs in Africa: Time to Consider Systems Complexity?-A Scoping Review. Trop. Med. Infect. Dis., 8.","DOI":"10.20944\/preprints202308.1670.v1"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.19-0117","article-title":"Prevalence of Chronic Hepatitis B Virus Infection among Children in Haiti, 2017","volume":"101","author":"Childs","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/22221751.2021.1899055","article-title":"Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus","volume":"10","author":"Lu","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_79","unstructured":"European Association for the Study of the Liver (2025). EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 83, 502\u2013583."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1093\/cid\/ciaa282","article-title":"Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level-Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study","volume":"71","author":"Segeral","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12072-021-10285-5","article-title":"Asian Pacific association for the study of liver (APASL) guidelines: Hepatitis B virus in pregnancy","volume":"16","author":"Kumar","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","article-title":"Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: A systematic review and meta-analysis","volume":"21","author":"Boucheron","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/aogs.14448","article-title":"Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis","volume":"101","author":"Yao","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cld.1096","article-title":"Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region","volume":"18","author":"Shan","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a117321","article-title":"Long-term follow-up of hepatitis B vaccine in infants of carrier mothers","volume":"140","author":"Marion","year":"1994","journal-title":"Am. J. Epidemiol."},{"key":"ref_86","first-page":"1534","article-title":"Strategy vaccination against Hepatitis B in China","volume":"11","author":"Liao","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","article-title":"Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis","volume":"21","author":"Funk","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2016.02.003","article-title":"Management of mother-to-child transmission of hepatitis B virus: Propositions and challenges","volume":"77","author":"Yi","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00404-019-05190-0","article-title":"Prevention of perinatal hepatitis B virus transmission","volume":"300","author":"Cheung","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41591-023-02782-x","article-title":"Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China","volume":"30","author":"Yin","year":"2024","journal-title":"Nat. Med."},{"key":"ref_91","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm. Rep."},{"key":"ref_92","unstructured":"WHO (2024). Immunization Dashboard: European Region, World Health Organization."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"648","DOI":"10.15585\/mmwr.mm7329a3","article-title":"Progress toward elimination of mother-to-child transmission of hepatitis B virus\u2014Region of the Americas, 2012\u20132022","volume":"73","author":"Alleman","year":"2024","journal-title":"Morb. Mortal. Wkly. Rep. (MMWR)"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.arcped.2014.06.020","article-title":"Is the new vaccination schedule recommended in France adapted to premature babies?","volume":"21","author":"Gaudelus","year":"2014","journal-title":"Arch. Pediatr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1080\/21645515.2015.1074358","article-title":"Immunization of preterm infants","volume":"11","author":"Gagneur","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2155390","DOI":"10.1080\/21645515.2022.2155390","article-title":"A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap","volume":"18","author":"Qin","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_98","unstructured":"World Health Organization (2017). Hepatitis B vaccines: WHO position paper\u2014July 2017. Wkly. Epidemiol. Rec., 92, 369\u2013392."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/FM9.0000000000000012","article-title":"Issues Meriting Further Study in Preventing Mother-to-Infant Transmission of Hepatitis B by Antiviral Therapy During Pregnancy","volume":"1","author":"Zhou","year":"2019","journal-title":"Matern.-Fetal Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/cid\/ciae288","article-title":"Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis","volume":"79","author":"Pan","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Chen, R., Zou, J., Long, L., Huang, H., Zhang, M., Fan, X., and Huang, Y. (2021). Safety and Efficacy of Tenofovir Alafenamide Fumarate in Early-Middle Pregnancy for Mothers with Chronic Hepatitis B. Front. Med., 8.","DOI":"10.3389\/fmed.2021.796901"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Chen, J.Z., Liao, Z.W., Huang, F.L., Su, R.K., Wang, W.B., Cheng, X.Y., Chen, J.Q., Liu, J.Q., and Huang, Z. (2017). Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-04479-x"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.14309\/ajg.0000000000003122","article-title":"Expected 8-Week Prenatal vs. 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial","volume":"120","author":"Zeng","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"ref_104","unstructured":"WHO (2024). Guidelines Approved by the Guidelines Review Committee. Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection, World Health Organization."},{"key":"ref_105","first-page":"318","article-title":"Acceptance of antiviral treatment and enhanced service model for pregnant patients carrying hepatitis B","volume":"26","author":"Hui","year":"2020","journal-title":"Hong Kong Med. J."},{"key":"ref_106","first-page":"605","article-title":"Vertical transmission of hepatitis B virus: Challenges and solutions","volume":"6","author":"Gentile","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1473-3099(22)00318-8","article-title":"Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): A multicentre, randomised, parallel-group, open-label, phase 2 trial","volume":"23","author":"Wedemeyer","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_108","unstructured":"WHO (2025, June 10). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Gao, L., Yang, J., Feng, J., Liu, Z., Dong, Y., Luo, J., Yu, L., Wang, J., Fan, H., and Ma, W. (2022). PreS\/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.856463"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Van Gulck, E., Concei\u00e7\u00e3o-Neto, N., Aerts, L., Pierson, W., Verschueren, L., Vleeschouwer, M., Krishna, V., N\u00e1jera, I., and Pauwels, F. (2024). Retreatment with HBV siRNA Results in Additional Reduction in HBV Antigenemia and Immune Stimulation in the AAV-HBV Mouse Model. Viruses, 16.","DOI":"10.3390\/v16030347"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nguyen, L., Nguyen, T.T., Kim, J.Y., and Jeong, J.H. (2024). Advanced siRNA delivery in combating hepatitis B virus: Mechanistic insights and recent updates. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-03004-3"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3851\/IMP2870","article-title":"CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model","volume":"20","author":"Hu","year":"2015","journal-title":"Antivir. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1002\/iid3.866","article-title":"CRISPR\/Cas9 for hepatitis B virus infection treatment","volume":"11","author":"Cai","year":"2023","journal-title":"Immun. Inflamm. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1484\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:14:48Z","timestamp":1762838088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":113,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["v17111484"],"URL":"https:\/\/doi.org\/10.3390\/v17111484","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]}}}